Back to Search Start Over

Parkinson's Disease Clinical Trials and Therapies 2023: Latest breakthroughs, Treatment Market, Therapies, and Companies by DelveInsight | Abbvie, Roche, Kissei Pharmaceutical, Lundbeck, AstraZeneca

Source :
M2 Presswire. April 19, 2023
Publication Year :
2023

Abstract

M2 PRESSWIRE-April 19, 2023-: Parkinson's Disease Clinical Trials and Therapies 2023: Latest breakthroughs, Treatment Market, Therapies, and Companies by DelveInsight | Abbvie, Roche, Kissei Pharmaceutical, Lundbeck, AstraZeneca (C)1994-2023 M2 COMMUNICATIONS [...]

Subjects

Subjects :
AstraZeneca PLC -- Reports
Business -- Research
Rasagiline -- Reports
Pramipexole -- Reports
Pharmaceutical industry -- Reports
Exenatide -- Reports
Business
Business, international

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Presswire
Publication Type :
News
Accession number :
edsgcl.746126842

Tools

Authors Abstract Subjects Details